• Mashup Score: 0
    Oncology Burst - 1 year(s) ago

    FDA approves pembrolizumab as adjuvant treatment for non-small cell lung cancer

    Source: U.S. Food and Drug Administration
    Categories: Hem/Oncs, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of Latinamd
      Latinamd

      Another adjuvant option in #lungcancer @FDAOncology approves #pembrolizumab as adjuvant tx for NSCLC based on #KEYNOTE091 N=1177 Stage IB-IIIA (regardless of PDL1 -despite subgroup analysis) best DFS on those receiving chemo: 58.7 mos vs 34.9 mos #lcsm https://t.co/CZGOMXDP6N

  • Mashup Score: 0
    Oncology Burst - 1 year(s) ago

    FDA approves pembrolizumab as adjuvant treatment for non-small cell lung cancer

    Source: U.S. Food and Drug Administration
    Categories: Hem/Oncs, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of Latinamd
      Latinamd

      Another adjuvant option in lung cancer @FDAOncology approves #pembrolizumab as adjuvant tx for NSCLC (based on #KEYNOTE091 N=1177 RCT Stage IB-IIIA (regardless of PDL1 expression) best DFS on those receiving chemo: 58.7 mos vs 34.9 mos @oncalert #lcsm https://t.co/CZGOMXDP6N

  • Mashup Score: 0
    Oncology Burst - 1 year(s) ago

    FDA approves pembrolizumab as adjuvant treatment for non-small cell lung cancer

    Source: U.S. Food and Drug Administration
    Categories: Hem/Oncs, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of Latinamd
      Latinamd

      Another adjuvant option in lung cancer @FDAOncology approves #pembrolizumab as adjuvant tx for NSCLC based on #KEYNOTE091 N=1177 RCT Stage IB-IIIA best DFS on those receiving chemo: 58.7 mos vs 34.9 mos @oncalert #lcsm https://t.co/CZGOMXDP6N